The trademark application RYPAZE was filed by Jazz Pharmaceuticals Ireland Limited, a corporation established under the laws of Ireland (the "Applicant"). The application was published for oppositions on October 10, 2021, and it was registered by office on January 17, 2022 without any oppositions.
The application was filed in English (French was selected as the second language).